DiaMed Diagnostic Germany GmbH

Click Here To EMAIL INQUIRY
Web: http://www.diamedgmbh.de
E-Mail:
Address: Heidemann Strasse 164, Munich D-80939, Germany
Phone: +49-(89)-45 23 07-0 | Fax: +49-(89)-45 23 07-18 | Map/Directions >>

Profile: DiaMed Diagnostic Germany GmbH is a supplier of products and services in the field of immunohaematology. Maestro MasterSoftware is a centralized data and instruments management software for immunohaematolog. It features complete traceability, centralized data management and connection to the network, intranet, external PC's (for external validations, access to database, instrument-control). DiaMed CD-2 is a coagulation analyzer. It features reduced reagent volume and measures all clotting based coagulation tests. The DiaMed CD-2 is a micro computer controlled coagulation instrument. 2-channel optics and blue low laser LED at 470 nm guarantees high precision and reproducibility. The CD-2 is suitable for PT, a-PTT, Fibrinogen, Thrombin time tests.

6 Products/Services (Click for related suppliers)

• Bothrops Atrox Reagent (FDA Code: JCO / 864.8100)

A Bothrops atrox reagent is a device made from snake venom and used to determine blood fibrinogen levels to aid in the evaluation of disseminated intravascular coagulation (nonlocalized clotting in the blood vessels) in patients receiving heparin therapy (the administration of the anticoagulant heparin in the treatment of thrombosis) or as an aid in the classification of dysfibrinogenemia (presence in the plasma of functionally defective fibrinogen).

• Fibrinogen Determination System Test (FDA Code: KQJ / 864.7340)

A fibrinogen determination system is a device that consists of the instruments, reagents, standards, and controls used to determine the fibrinogen levels in disseminated intravascular coagulation (nonlocalized clotting within the blood vessels) and primary fibrinolysis (the dissolution of fibrin in a blood clot).

• Partial Thromboplastin Test Time (FDA Code: GGW / 864.7925)

A partial thromboplastin time test is a device used for primary screening for coagulation abnormalities, for evaluation of the effect of therapy on procoagulant disorders, and as an assay for coagulation factor deficiencies of the intrinsic coagulation pathway.

• Prothrombin Time Test (FDA Code: GJS / 864.7750)

A prothrombin time test is a device used as a general screening procedure for the detection of possible clotting factor deficiencies in the extrinsic coagulation pathway, which involves the reaction between coagulation factors III and VII, and to monitor patients receiving coumarin therapy (the administration of one of the coumarin anticoagulants in the treatment of venous thrombosis or pulmonary embolism).

• Qualitative and Quantitative Factor Deficiency Test (FDA Code: GGP / 864.7290)

A factor deficiency test is a device used to diagnose specific coagulation defects, to monitor certain types of therapy, to detect coagulation inhibitors, and to detect a carrier state (a person carrying both a recessive gene for a coagulation factor deficiency such as hemophilia and the corresponding normal gene).

• Thrombin Time Test (FDA Code: GJA / 864.7875)

A thrombin time test is a device used to measure fibrinogen concentration and detect fibrin or fibrinogen split products for the evaluation of bleeding disorders.